Identity
- Security key
- 15096
- Ticker
- EYPT
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2005-01-27
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- EYPT
Detail
Enriched 2026-08-14 20:47
- Market cap
- $1,166,450,227.14
- Shares outstanding (class)
- 86,212,138
- Shares outstanding (weighted)
- 86,212,138
- SIC
- 3826 LABORATORY ANALYTICAL INSTRUMENTS
- Employees
- 214
- Location
- WATERTOWN, MA
- Homepage
- https://www.eyepoint.bio
- Description
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.